Co-Authors
This is a "connection" page, showing publications co-authored by Valérie Pourcher and Elisabeth Maillart.
Connection Strength
0.340
-
Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies? Mult Scler Relat Disord. 2020 Nov; 46:102482.
Score: 0.225
-
Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders. J Neurol Neurosurg Psychiatry. 2022 01; 93(1):24-31.
Score: 0.060
-
Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum. Rev Neurol (Paris). 2020 06; 176(6):523-525.
Score: 0.055